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The role of boronic acids in accelerating
condensation reactions of α-eﬀect amines
with carbonyls
Dennis Gillingham
A broad palette of bioconjugation reactions are available for chemical biologists, but an area that still
requires investigation is high-rate constant reactions. These are indispensable in certain applications,
particularly for in vivo labelling. Appropriately positioned boronic acids accelerate normally sluggish Schiﬀ
base condensations of α-eﬀect nucleophiles by ﬁve orders of magnitude – providing a new entry to
the rare set of reactions that have a rate constant above 100 M−1 s−1 under physiological conditions.
I summarize here a number of recent reports, including work from my own group, and outline a
mechanistic picture that explains the diﬀering behaviour of seemingly similar substrate classes.
Introduction
Bioorthogonal ligation reactions1 that operate in water at
neutral pH and have high second order rate constants are rare
and yet serve important niches of chemical biology.2,3 A recent
article from the Bode group outlines in detail the specific scen-
arios where high rate constants are necessary2 – I recap here
the main points:
• if one or both components are precious then running
under pseudo-first order conditions to achieve a high-rate may
not be viable
• components with a high molecular weight (proteins,
nucleic acids, PEG units) simply cannot be dissolved at high
molar concentration
• large excesses of reagent in live cell or whole animal
experiments often lead to confounding eﬀects
• for fluorescent labelling large excesses of a reagent give
high background signal or require additional washing steps
before imaging
• high-rate constants reduce the necessary incubation times.
Recently my group has shown that the venerable oxime
condensation can be accelerated by more than five orders of
magnitude by including an appropriately positioned boronic
acid in the carbonyl substrate.4 Others have demonstrated that
this eﬀect holds with other types of α-eﬀect amine conden-
sations.5 In this Perspective I have collected the key results
from previous reports on boron-accelerated condensations and
attempted to synthesize this into a mechanistic picture that
explains the special role of the boron atom in the process.
The inverse-electron demand Diels–Alder reaction of
strained olefins with tetrazines (TIEDDA) is currently the
fastest ligation reaction used in chemical biology with second
order rate constants upwards of 106 M−1 s−1 for optimized
substrate pairs.6 The success of the TIEDDA reaction notwith-
standing, having a handful of such transformations would be
helpful in, for example, dual-labelling experiments,7 where two
orthogonal reactions are required, or in cases where the dis-
advantages of the Diels–Alder reaction preclude its application
(when the footprint interferes with function, or when the
substrate syntheses are too demanding).
Discussion
The oxime condensation is a workhorse in chemical biology
because the starting materials are readily available and the
reaction is extremely reliable.8 Its rate, however, is slow with a
maximum between pH 4 and 5.9 For such condensations of
α-eﬀect amines (O-alkylhydroxylamines, hydrazines, hydra-
zones) with carbonyls Jencks had shown that aniline could
serve as a nucleophilic catalyst.10 Dawson developed this idea
further to create the aniline catalysis protocol,11 which is
widely used for oxime/hydrazone ligations in chemical biology.
With aniline catalysis oxime and hydrazone condensations can
proceed with rate constants of up to 8 M−1 s−1.12 But the
requirement for a catalyst (typically at high concentration)
inherently reduces the scope of the catalysis approach to
in vitro or cell surface labelling.13
There are few small molecule ligation reactions that operate
under physiological conditions with second order rate con-
stants above 100 M−1 s−1.14 Two processes that meet these
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standards – and consequently are widely used in chemical
biology – are the TIEDDA reaction with strained olefins and
certain variants of the copper catalysed azide–alkyne cyclo-
addition (CuAAC).15,16 Aside from the disadvantage of requir-
ing an added catalyst, the CuAAC reaction is also hamstrung
by the cellular toxicity of copper.17 Over the past seven years
since its rediscovery as a reaction in chemical biology, the
TIEDDA process with strained olefins has proven to be robust
and broadly applicable, even being used for imaging in whole
animals.18 Despite the complexity (and sometimes instability)
of the reaction partners and the large chemical footprint left
by this reaction, it is broadly used because of its combination
of speed, chemoselectivity, and bioorthogonality.18–21 While
the TIEDDA reaction has pushed the boundaries of what’s
possible in chemical biology, it has not supplanted oxime con-
densations and CuAAC reactions for day-to-day couplings
because these reactions are easy to engineer, sterically lean,
and the starting materials can be stored without decompo-
sition. The ideal would be for the simplest reactions (oxime
condensation, CuAAC reaction) to also have enzyme-like rate
constants. While ligand refinement or copper chelation seem
most promising for optimizing CuAAC reactions,15,22,23 it is
the precise positioning of boronic acids in the carbonyl sub-
strate that has elevated oxime and hydrazone condensations
into rate regimes of up to 104 M−1 s−1.4,5
While there were scattered reports that boron could lead to
stabilization of normally labile Schiﬀ bases,24–27 it was two
reports in 2012 that pointed towards the potential of this eﬀect
in chemical biology.28,29 These demonstrated that boronic
acids positioned near the carbonyl group led to stable Schiﬀ
bases with amines in whole proteins28 or in aminoglycoside
antibiotics29 in aqueous buﬀer. Recent work has applied boro-
nate-stabilized Schiﬀ base formation to the labelling of cell
surface amines in bacteria,30 and in the reversible formation
of cyclic peptides.31 In 2015 my group4 and the Gao lab5 pub-
lished almost simultaneously that α-eﬀect amines condensed
with boronic acid-bearing carbonyl substrates at rates far
above normal oxime condensations. My group focussed on
oximes formed from 2-formylphenylboronic acid (2-FPBA)
while the Gao lab took a broader look at the α-eﬀect amines
with 2-acetylphenylboronic acid (2-APBA). Taken together the
results from my lab and the Gao lab suggest that 2-FPBA
adducts are more stable and better suited to bioconjugation,
while 2-APBA adducts are more labile and better suited to
applications like dynamic combinatorial chemistry.
To understand the impact of boronic acids on these con-
densations it is instructive to compare diﬀerent scenarios with
and without boronic acids. In normal Schiﬀ base formation
there is a rapid addition equilibrium of the nucleophile to the
carbonyl followed by a dehydration step (often rate-limiting) to
give the Schiﬀ base (see A in Fig. 1).9 Both steps are reversible
and in water the Schiﬀ base is disfavoured by le Chatelier’s
principle applied on the relatively small equilibrium constant
for imines (typically <100 M−1).32 With boronic acids several
eﬀects likely stabilize the Schiﬀ bases: in structure 4 (Fig. 1)
both the hydrogen bond and the coulombic interaction
operate in concert (as is well-established with pyridoxyl phos-
phate-derived imines)32 to stabilize the Schiﬀ base relative to
the benzaldehyde imine – this mode of stabilization turns out
to be most prevalent with 2-FPBA derived imines.29 With
2-APBA imines, on the other hand, calculations suggest that a
Lewis acid/base interaction to form an iminoboronate is the
key stabilizing force.28 Although they are more stable than
normal imines, structures related to 5 have low kinetic barriers
and re-equilibrate in seconds upon perturbation irrespective of
whether they are imines,28 hydrazones,5 or oximes.33 For the
ground states, however, it has so far not been determined
whether structures such as 4 or 5 in the hydrazone or oxime
series are more stable than the parent derivatives lacking a
boronic acid (such as 3b-c). A crystal structure of a boronic
acid bearing oxime provides the only insight, and suggests
that at least in the case of oximes the iminoboronate structure
is not a substantial contributor to ground state energies of
aldoximes.33
How does boronic acid substitution lead to such a large
change in kinetic barriers? The addition equilibrium in all
types of Schiﬀ base formation is typically rapid and hence the
major change is likely in the dehydration step. Boronic acids
are in an equilibrium with the boronate form in water and the
indirect pKa associated with water addition is approximately
7 depending on substitution. For example the hemiaminal
equilibrium shown in the bottom of Fig. 2 has a pKa of 7.4.
34
Coming back to oxime condensations, upon addition of a
nucleophile the resulting tetrahedral intermediate can sub-
stitute for a water on the boron to give a cyclic boronate (as
shown in structure 6 of panel B in Fig. 1). In a normal oxime
condensation the O-alkylhydroxylamine is more basic than the
alcohol lone pair in the hemiaminal intermediate (compare
competing transition states 7 & 8 in Fig. 2); hence transition
state 8 is preferred and the forward reaction is correspondingly
slower. When boron is present the competition is now the
Fig. 1 Schiﬀ base formations (A) and the impact that boronic acids
might have on their ground states and transition states (B).
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boronate versus the protonated O-alkylhydroxylamine as the
leaving group. The preference for boronate elimination favors
productive oxime formation (see 6 in Fig. 2) leading to faster
rates than in the parent oxime formation. The direct involve-
ment of the vacant boron p-orbital is further supported by
experiments where tripodal ligands or fluoride substituents on
the boron abolished the rate acceleration.33
A disadvantage of the boron-assisted Schiﬀ base formations
is their reversibility. The aldoxime formations with 2-formyl-
phenylboronic acid that we have reported give the most kineti-
cally stable adducts but even these have a reverse rate constant
of 4.2 ± 0.4 × 10−5 s−1, meaning adducts can be hydrolysed
completely in about half a day. Oxime condensations with 2-
FPBA do, however, have large equilibrium constant of >108
M−1, and this mitigates the reversibility problem since even at
nanomolar concentration of starting materials the oxime will
predominate at equilibrium. Nevertheless for cellular studies
where compartmentalization could keep systems out of equili-
brium it would be ideal to have an irreversible linkage. Work
from my group33 as well as Susan Bane’s lab35 has recently
identified an irreversible variant in the hydrazone series (see
Fig. 3). It turns out that when hydrazines are condensed with
2-FPBA the hydrazone adducts undergo a secondary cyclization
reaction to create aromatic borazaroisoquinolines (BIQs, see
structure 11 in Fig. 3). BIQs are robust and their formation is
irreversible.36 The extended aromatic ring created upon BIQ
formation opens the door to modulating its photophysical pro-
perties – indeed we have exploited this feature to create a blue
fluorescent turn-on fluorophore (see bottom of Fig. 3).
Although in chemical biology red and near-infrared fluoro-
phores are in greater need than blue ones, the ability to
build a turn-on fluorophore in such short order is a promising
start towards creating more practical variants.
Future outlook
The next major step for boron-assisted oxime ligations or BIQ
formations is to prove they can operate in vivo with high
eﬃciency. We have already shown that the reaction is
unaﬀected when run in cell lysates and in the presence of
common biological interfering agents,4 but the area of greatest
unmet need in chemical biology is in in vivo chemical liga-
tions. We are currently working on this problem.
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